Axsome Therapeutics (AXSM) Work In Process (2022 - 2026)

Axsome Therapeutics' Work In Process history runs 5 years deep, the most recent figure standing at $15.5 million for Q1 2026.

• In Q1 2026, Work In Process rose 127.41% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $15.5 million (up 127.41% YoY), while the FY2025 annual figure was $17.8 million, up 130.95% from the prior year.
• Work In Process came in at $15.5 million for Q1 2026 at Axsome Therapeutics, down from $17.8 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $17.8 million in Q4 2025 to a low of $6.8 million in Q1 2025.
• A 5-year average of $11.0 million and a median of $10.5 million in 2024 frame the typical range for Work In Process.
• On a YoY basis, Work In Process climbed as much as 130.95% in 2025 and fell as far as 37.64% in 2025.
• Axsome Therapeutics' Work In Process stood at $14.0 million in 2022, then decreased by 26.34% to $10.3 million in 2023, then declined by 24.92% to $7.7 million in 2024, then surged by 130.95% to $17.8 million in 2025, then declined by 13.34% to $15.5 million in 2026.
• According to Business Quant data, Work In Process over the past three periods registered $15.5 million, $17.8 million, and $12.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison